tiprankstipranks
Trending News
More News >
Aarti Drugs Limited (IN:AARTIDRUGS)
:AARTIDRUGS
India Market

Aarti Drugs Limited (AARTIDRUGS) Financial Statements

Compare
3 Followers

Aarti Drugs Limited Financial Overview

Aarti Drugs Limited's market cap is currently ₹35.15B. The company's EPS TTM is ₹4.9; its P/E ratio is 17.65; and it has a dividend yield of 0.24%. Aarti Drugs Limited is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is ₹4.90. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 23.87B₹ 25.29B₹ 27.16B₹ 24.89B₹ 21.55B
Gross Profit₹ 8.45B₹ 8.51B₹ 3.69B₹ 3.89B₹ 6.00B
Operating Income₹ 7.33B₹ 2.69B₹ 2.65B₹ 2.88B₹ 3.96B
EBITDA₹ 2.87B₹ 3.25B₹ 3.12B₹ 3.44B₹ 4.42B
Net Income₹ 1.68B₹ 1.71B₹ 1.66B₹ 2.05B₹ 2.80B
Balance Sheet
Cash & Short-Term Investments₹ 226.10M₹ 89.28M₹ 211.70M₹ 343.81M₹ 219.84M
Total Assets₹ 25.75B₹ 24.32B₹ 24.21B₹ 22.08B₹ 17.66B
Total Debt₹ 6.15B₹ 5.64B₹ 6.09B₹ 5.43B₹ 3.51B
Net Debt₹ 6.08B₹ 5.58B₹ 6.00B₹ 5.21B₹ 3.42B
Total Liabilities₹ 12.05B₹ 11.50B₹ 12.29B₹ 11.72B₹ 8.53B
Stockholders' Equity₹ 13.69B₹ 12.82B₹ 11.92B₹ 10.36B₹ 9.13B
Cash Flow
Free Cash Flow₹ 674.20M₹ 1.33B₹ -304.70M₹ -823.39M₹ 667.19M
Operating Cash Flow₹ 2.45B₹ 3.59B₹ 1.34B₹ 696.36M₹ 1.55B
Investing Cash Flow₹ -1.65B₹ -2.24B₹ -1.64B₹ -1.49B₹ -716.79M
Financing Cash Flow₹ -821.20M₹ -1.36B₹ 165.40M₹ 920.25M₹ -811.29M
Currency in INR

Aarti Drugs Limited Earnings and Revenue History

Aarti Drugs Limited Debt to Assets

Aarti Drugs Limited Cash Flow

Aarti Drugs Limited Forecast EPS vs Actual EPS